Search research articles
Contact Us
Filters
Showing results (41-50 of 116) with videos related to
Page
of 12
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
April 21, 2018
Visual and semi-automatic non-invasive detection of interictal fast ripples: A potential biomarker of epilepsy in children with tuberous sclerosis complex
Danilo Bernardo, Hiroki Nariai, Shaun A Hussain, et al.
Epilepsy & Behavior : E&B
|
May 27, 2019
fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy
Jane B Allendorfer, Rodolphe Nenert, E Martina Bebin, et al.
Clinical Pharmacology and Therapeutics
|
August 31, 2021
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy
Brittney H Davis, T Mark Beasley, Michelle Amaral, et al.
Pediatric Neurology
|
August 3, 2021
Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis Complex
S Katie Z Ihnen, Jamie K Capal, Paul S Horn, et al.
Epilepsia
|
October 29, 2024
Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complex
S Katie Z Ihnen, Samuel Alperin, Jamie K Capal, et al.
Pediatrics
|
November 5, 2017
Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants
Peter E Davis, Rajna Filip-Dhima, Georgios Sideridis, et al.
JAMA Neurology
|
December 21, 2020
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial
Elizabeth A Thiele, E Martina Bebin, Hari Bhathal, et al.
Plos One
|
September 8, 2018
Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis
John J Bissler, Norio Nonomura, Klemens Budde, et al.
Annals of Neurology
|
April 29, 2014
UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration
Akl C Fahed, Barbara McDonough, Cynthia M Gouvion, et al.
Computers in Biology and Medicine
|
May 6, 2026
A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex
Cancan Zhang, Runqiu Wang, Jamie K Capal, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 116) with videos related to
Sort By:
Page
of 12
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
April 21, 2018
Visual and semi-automatic non-invasive detection of interictal fast ripples: A potential biomarker of epilepsy in children with tuberous sclerosis complex
Danilo Bernardo, Hiroki Nariai, Shaun A Hussain, et al.
Epilepsy & Behavior : E&B
|
May 27, 2019
fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy
Jane B Allendorfer, Rodolphe Nenert, E Martina Bebin, et al.
Clinical Pharmacology and Therapeutics
|
August 31, 2021
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy
Brittney H Davis, T Mark Beasley, Michelle Amaral, et al.
Pediatric Neurology
|
August 3, 2021
Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis Complex
S Katie Z Ihnen, Jamie K Capal, Paul S Horn, et al.
Epilepsia
|
October 29, 2024
Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complex
S Katie Z Ihnen, Samuel Alperin, Jamie K Capal, et al.
Pediatrics
|
November 5, 2017
Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants
Peter E Davis, Rajna Filip-Dhima, Georgios Sideridis, et al.
JAMA Neurology
|
December 21, 2020
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial
Elizabeth A Thiele, E Martina Bebin, Hari Bhathal, et al.
Plos One
|
September 8, 2018
Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis
John J Bissler, Norio Nonomura, Klemens Budde, et al.
Annals of Neurology
|
April 29, 2014
UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration
Akl C Fahed, Barbara McDonough, Cynthia M Gouvion, et al.
Computers in Biology and Medicine
|
May 6, 2026
A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex
Cancan Zhang, Runqiu Wang, Jamie K Capal, et al.
Page
of 12